Marriaga NB, Solorzano SF

Language: Spanish
References: 6
Page: 61-62
PDF size: 71.69 Kb.

Text Extraction

No abstract.

REFERENCES

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology,and clinical manifestations of respiratory infectionsdue to Bordetella pertussis and other Bordetellasubspecies. Clin Microbiol Rev 2005; 18: 326-382.

2. Colsa-Ranero A, Macías-Parra M, Hernández-Porras M,Xochihua-Díaz L, Galindo-Fraga A, Moreno-Espinosa S,Solórzano-Santos F. An expert panel opinion on protectionagainst pertussis in Mexico: The role of acellularand whole-cell vaccines. Bol Med Hosp Infant Mex.2022; 79 (3):152-160.

3. (Echaniz-Aviles G, García-Cisneros S, Sánchez-AlemánMA, Olamendi-Portugal M, Romero-Martinez M,Deantonio R, Cervantes-Apolinar MY, Ortega-Barria E,Cortes-Alcala R, Alpuche-Aranda CM. Estimating Bordetellapertussis seroprevalence in adolescents andyoung adults in Mexico using the 2012 National Healthand Nutrition Survey (ENSANUT). Vaccine. 2021; 39 (40):5839-5844).

4. Domenech de Cellès M, Magpantay FM, King AA, RohaniP. The pertussis enigma: reconciling epidemiology,immunology and evolution. Proc Biol Sci. 2016; 283(1822): 20152309)

5. https://www.gob.mx/cms/uploads/attachment/file/990643/Bolet_n_informativo_2_EPV_18_de_abril_del_2025.pdf

6. Navarrete E, Laris-González A, Castro-Díaz AD, Rosales-Pedraza G, Moreno-Espinosa S, Rosa-Zamboni D.Seroprevalence of Bordetella pertussis in pediatric healthcareworkers at the Hospital Infantil de México FedericoGómez. Bol Med Hosp Infant Mex. 2019; 76 (3): 120-125.